An experimental therapy being developed by Amgen and Novartis to prevent migraine has been accepted for review in the European Union.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.
Copyright © 2016-2018 Drugdu.com. All Rights Reserved.